Roundtable Discussion: Harnessing Short-Lived Alpha Emitters to Maximize the Therapeutic Benefit of Combination Strategies

12:30 pm - Thursday 25th February 2027

Understanding how short, high-intensity alpha irradiation alters tumor biology to identify opportunities for synergistic combination therapies
Combining alpha therapy with immunotherapy & other treatment modalities to enhance anti-tumor response beyond RLT alone
Optimizing isotope half-life, treatment timing, & sequencing to maximize the therapeutic benefit of combination strategies